Article Versions Notes

Medjedovic L, Vižlin A, Andersch Björkman Y, Albertsson A-M, Raghavan S, Gillstedt M, Osmancevic A. Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors. International Journal of Molecular Sciences. 2026; 27(1):458. https://doi.org/10.3390/ijms27010458

Medjedovic, Lucia, Admir Vižlin, Ylva Andersch Björkman, Anna-Maj Albertsson, Sukanya Raghavan, Martin Gillstedt, and Amra Osmancevic. 2026. "Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors" International Journal of Molecular Sciences 27, no. 1: 458. https://doi.org/10.3390/ijms27010458

Medjedovic, L., Vižlin, A., Andersch Björkman, Y., Albertsson, A.-M., Raghavan, S., Gillstedt, M., & Osmancevic, A. (2026). Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors. International Journal of Molecular Sciences, 27(1), 458. https://doi.org/10.3390/ijms27010458